Mounjaro®
Starting from £179.99/mo
Start journey Learn moreHair shedding during Mounjaro treatment is real, but it is not caused by the medicine itself — it is almost always a response to rapid weight loss, and it is temporary. Women on tirzepatide report noticing increased hair fall around two to four months into treatment, at a point when the scales are moving quickly. Understanding why this happens, and what to do, makes it far less alarming. Because Mounjaro is a prescription-only medicine, a GPhC-registered prescriber assesses your full health picture before treatment begins — and that conversation is the right place to raise any concerns about hair changes before they start.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common thing women search after noticing hair fall on tirzepatide is whether the medicine is damaging their follicles. The short answer is: the available evidence does not support that. Hair loss does not appear in the Mounjaro prescribing information as a direct pharmacological effect of tirzepatide itself. What the clinical literature does describe is telogen effluvium, a well-understood, temporary shift in the hair growth cycle triggered by physiological stress.
When the body loses weight quickly, it interprets the calorie deficit as a significant internal stressor. Hair follicles respond by moving from the active growth phase into a resting phase (telogen) earlier than usual. Around two to four months later, those hairs shed together, which is why the timing often aligns with the period when Mounjaro's appetite-suppressing effect is most pronounced and weight loss is fastest. You can read about tirzepatide's overall side-effect profile on the Mounjaro side effects page, where the GI effects that tend to dominate the early weeks are covered in full.
This same pattern of shedding is seen after bariatric surgery, very low calorie diets, and other causes of rapid weight change. Mounjaro accelerates the weight-loss trajectory, and for some women that means encountering telogen effluvium who might not have experienced it with a slower approach. The NHS notes that hair loss can be caused by sudden weight loss and dietary changes, framing it as a recognised physical response, not a rare drug reaction. There is a fuller look at the female-specific picture on our Mounjaro side effects in females page.
Hair shedding on Mounjaro is not universal. Women who lose weight very rapidly in the first few months, eat significantly fewer calories than their bodies need, or take in too little protein are more likely to notice pronounced shedding. Protein is the raw material for keratin (the structural protein hair is made of) and when intake drops, the body prioritises other functions. A common clinical recommendation during rapid weight loss is to aim for adequate daily protein spread across meals; your prescriber or a registered dietitian can advise on what that looks like for you specifically.
Iron deficiency is worth raising with your GP or prescriber, particularly for women who experience heavy periods. A ferritin level that was borderline before treatment can dip further during calorie restriction, and low iron stores are independently associated with hair shedding. Thyroid function is another variable worth checking if shedding is persistent or accelerating, since both hypothyroidism and hyperthyroidism can drive hair loss and may go unnoticed if weight change is attributed to treatment alone.
Women who want to read about whether this pattern shows up in other patients' accounts can find a range of perspectives on our Mounjaro hair loss reviews: female experiences page. The patterns that emerge there are consistent with what the clinical framing above would predict.
Most hair shedding associated with rapid weight loss is self-limiting. That said, there are situations where you should speak to a doctor or your prescriber promptly. Seek advice if: shedding is severe enough that you can see thinning patches or a noticeably reduced hairline; hair loss has not improved after six months of stable weight; you develop scalp inflammation, scaling or pain; or you notice brow, lash or body hair loss alongside scalp changes, which can suggest a different process such as alopecia areata.
Mounjaro carries a Black Triangle (▼) designation, meaning the MHRA actively collects data on its safety profile as experience with the medicine grows in the UK. If you experience a side effect that concerns you (including hair changes you believe are linked to treatment) you can report it directly via the Yellow Card scheme. That reporting genuinely contributes to the post-market safety picture for these newer medicines.
The NHS tirzepatide medicine page is a reliable first reference for the full list of reported side effects and the specific circumstances that warrant urgent medical attention. If nausea is also a significant issue alongside the hair changes (a combination some women describe) there is more detail on managing that on our Mounjaro and persistent nausea page.
At a nume consultation, side effects including hair shedding are part of the clinical conversation, not an afterthought. A GPhC-registered prescriber reviews your answers on the same day you submit them. That means questions about your hair, your nutrition, your menstrual cycle and any existing conditions that might compound shedding are factored in before treatment is recommended, not flagged weeks in, when you're already worried.
Practical steps that the evidence supports during treatment: maintain protein intake of at least 1.2–1.6g per kg of body weight daily (your prescriber or dietitian can refine this); ask your GP to check ferritin and thyroid function if shedding is significant; avoid aggressive heat styling or tight hairstyles that add mechanical stress to fragile growth-phase hairs; and give treatment time, regrowth usually follows as weight stabilises. If you are wondering whether stopping Mounjaro is the answer, that decision has its own considerations, which our page on managing hair loss on Mounjaro for women covers thoroughly.
For a broader look at what the medicine does and how it fits within a weight-management plan, the Mounjaro overview page is a good starting point. And if you are ready to discuss suitability with a prescriber, our free consultation is there, no waiting list, plain packaging via tracked delivery, and a real clinician reading your notes the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.